SolutionsAbout UsOur WorkContact
WORK TAGGED:

News

Sort by
All Work
White Paper
Blog Post
Data Snack
Video
News
Sort By
All Work
White Paper
Blog Post
Data Snack
Video
News
June 2025
Perceived AID Algorithm Performance and Hypoglycemia Prevalence in PWD

dQ&A data show that users' perceptions of an algorithm's aggressiveness strongly impact satisfaction and NPS.

Read More
Data Snack
June 2025
Paradigm Shifts in GLP-1 Receptor Agonist Use Amongst Patients with T2 in the USA

About 10% of Americans have Type 2 diabetes (T2), often along with obesity and heart disease.

Read More
Data Snack
June 2025
How Menstruation Affects Diabetes Management in the USA and EU

Despite clear evidence that hormonal fluctuations during menstruation impact blood glucose, these effects are often overlooked in diabetes care.

Read More
Data Snack
June 2025
Highlights from ADA 2025: Access dQ&A’s Latest Posters

dQ&A presented three research abstracts at the 85th Scientific Sessions of the American Diabetes Association (ADA), the world’s largest diabetes conference.

Read More
Data Snack
June 2025
dQ&A Patient Voice 2025

dQ&A is announcing the availability of new data collected this quarter from ten thousand people with diabetes in the USA, Canada and seven EU countries.

Read More
White Paper
June 2025
Why Being a Diabetes Moderator is the Best Job in the World

dQ&A moderators have the skills and expertise to extract top-quality, real-time, valuable insights directly from people living with diabetes and health care providers.

Read More
Data Snack
May 2025
A Focus on Drivers Analysis

Drivers Analysis is a sophisticated statistical technique that delivers penetrating, next-level insights by disentangling the underlying causes of specific outcomes – so you learn not only ’what’ but ‘why’.

Read More
Data Snack
April 2025
Are HCPs Discussing CGM With Those in Need?

Results from dQ&A Patient Voice Q1 2025 Update

Read More
Data Snack
April 2025
The Time Has Come:
Adjunct Therapies for Type 1 Diabetes

Given that T1D patients share many of the same comorbidities as T2D patients, doctors have been prescribing them to T1D patients ‘off label’.

Read More
1 / 11
Subscribe to our newsletter
Receive our latest updates and
insights in your inbox.
ContactAbout
Our WorkSolutions
PrivacyTerms & Conditions
© 2025 dQ&A all rights reserved